Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and... see more

TSX:WEED - Post Discussion

Canopy Growth Corp > New Coverage
View:
Post by sollmg on Jun 19, 2024 9:43pm

New Coverage

 

 GLOBE says new coverage rates Canopy "sector perform"

 

2024-06-19 07:59 ET - In the News

 

The Globe and Mail reports in its Wednesday, June 19, edition that ATB Capital Markets analyst Frederico Gomes has started coverage on Canopy Growth with a "sector perform" recommendation and $10 share target. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $9.13. Mr. Gomes says in a sector "deprived of trading liquidity and institutional engagement," Canopy Growth "delivers a differentiated proposition." Mr. Gomes notes that Canopy is the only company offering direct exposure to cannabis markets in Canada, the United States and Europe, along with a Nasdaq listing. He believes Canopy's valuation "already prices in reasonable growth expectations." Mr. Gomes says in a note: "A comprehensive transformation of Canopy's core business is driving margins in the right direction and reducing cash use, materially derisking the investment case for Canopy. Management has divested assets and transitioned to an asset-light model in Canada, resulting in a cost structure more commensurate with its addressable market and a keener focus on profitability. ... Over the long-term, we think Canopy will re-gain share in Canada as the market rationalizes.

Comment by charlie007 on Jun 20, 2024 8:24am
with good news this could double but it may not hold long because of weak financials and ongoing dilution so timing is evrrything
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities